Ihuman Ownership
| IH Stock | USD 3.17 0.13 4.28% |
Ihuman Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 1.25. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ihuman Inc last dividend was issued on the 17th of April 2025. iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the Peoples Republic of China. The company was founded in 1996 and is based in Beijing, the Peoples Republic of China. Ihuman Inc operates under Education Training Services classification in the United States and is traded on New York Stock Exchange. It employs 1119 people. To learn more about Ihuman Inc call Peng Dai at 86 10 5780 6606 or check out https://www.ihuman.com.Ihuman Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Ihuman is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ihuman Inc backward and forwards among themselves. Ihuman's institutional investor refers to the entity that pools money to purchase Ihuman's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 88.8 K | Citadel Advisors Llc | 2025-03-31 | 55.5 K | Two Sigma Securities, Llc | 2025-03-31 | 46.7 K | Hrt Financial Llc | 2025-03-31 | 18.4 K | Acadian Asset Management Llc | 2025-03-31 | 15.1 K | Virtu Financial Llc | 2025-03-31 | 12.2 K | Crédit Agricole S.a. | 2025-03-31 | 10 K | Bnp Paribas Arbitrage, Sa | 2025-03-31 | 4 K | Ubs Group Ag | 2025-03-31 | 1.1 K | Rhumbline Advisers | 2025-03-31 | 934 |
Ihuman Outstanding Bonds
Ihuman issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ihuman Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ihuman bonds can be classified according to their maturity, which is the date when Ihuman Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| iHeartCommunications 6375 percent Corp BondUS45174HBC07 | View | |
| iHeartCommunications 8375 percent Corp BondUS45174HBD89 | View | |
| iHeartCommunications 475 percent Corp BondUS45174HBG11 | View | |
| US451713AA92 Corp BondUS451713AA92 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.287 | Earnings Share 0.26 | Revenue Per Share | Quarterly Revenue Growth (0.10) | Return On Assets |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.